2023
DOI: 10.1002/ejic.202300078
|View full text |Cite
|
Sign up to set email alerts
|

Ruthenium(II) Tris‐Pyrazolylmethane Complexes in Transfer Hydrogenation Reactions

Abstract: While ruthenium(II) arene complexes have been widely investigated for their potential in catalytic transfer hydrogenation, studies on homologous compounds replacing the arene ligand with the six‐electron donor tris(1‐pyrazolyl)methane (tpm) are almost absent in the literature. The reactions of [RuCl(κ3‐tpm)(PPh3)2]Cl, 1, with a series of nitrogen ligands (L) proceeded with selective PPh3 mono‐substitution, affording the novel complexes [RuCl(κ3‐tpm)(PPh3)(L)]Cl (L=NCMe, 2; NCPh, 3; imidazole, 4) in almost quan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 95 publications
0
2
0
Order By: Relevance
“…Bresciani et al (2023) [146] presented a study regarding the antitumor potential of several dinuclear Ru biscyclopentadienyl carbonyl complexes (23)(24)(25)(26) against A549 (lung), SW480 (colon), and A2780 and A2780cis (ovarian) cancer cell lines, as well as the nontumoral HEK-293 cell line. Cisplatin was used as the standard (IC 50 = 43 ± 3 µM, 35 ± 2 µM, 8.3 ± 1.4 µM, and 30 ± 3 µM, respectively, against cancer cell lines).…”
Section: Preclinical In Vitro and In Vivo Studies On Ru(ii) Complexes...mentioning
confidence: 99%
See 1 more Smart Citation
“…Bresciani et al (2023) [146] presented a study regarding the antitumor potential of several dinuclear Ru biscyclopentadienyl carbonyl complexes (23)(24)(25)(26) against A549 (lung), SW480 (colon), and A2780 and A2780cis (ovarian) cancer cell lines, as well as the nontumoral HEK-293 cell line. Cisplatin was used as the standard (IC 50 = 43 ± 3 µM, 35 ± 2 µM, 8.3 ± 1.4 µM, and 30 ± 3 µM, respectively, against cancer cell lines).…”
Section: Preclinical In Vitro and In Vivo Studies On Ru(ii) Complexes...mentioning
confidence: 99%
“…Among the precious metals, ruthenium (Ru) has singular physicochemical properties, which makes it particularly useful in drug design [19]. Ru complexes represent an important class of metallo-organic compounds with numerous applications, and they are currently used in the fields of catalysis [20][21][22][23], including homogeneous, heterogeneous, and photocatalysis [24]. Moreover, numerous biological activities, such as antifungal [25], antibacterial [26], and anticarcinogenic [27][28][29][30][31][32], have been described for the complexes of Ru, as well as their uses in neurodegenerative diseases [33].…”
Section: Introductionmentioning
confidence: 99%